CN1043307C - Drug for exterior use for treating necrosis of femoral head - Google Patents

Drug for exterior use for treating necrosis of femoral head Download PDF

Info

Publication number
CN1043307C
CN1043307C CN94114838A CN94114838A CN1043307C CN 1043307 C CN1043307 C CN 1043307C CN 94114838 A CN94114838 A CN 94114838A CN 94114838 A CN94114838 A CN 94114838A CN 1043307 C CN1043307 C CN 1043307C
Authority
CN
China
Prior art keywords
radix
femoral head
medicine
necrosis
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN94114838A
Other languages
Chinese (zh)
Other versions
CN1121817A (en
Inventor
黄克勤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN94114838A priority Critical patent/CN1043307C/en
Publication of CN1121817A publication Critical patent/CN1121817A/en
Application granted granted Critical
Publication of CN1043307C publication Critical patent/CN1043307C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses an external-use medicine for treating femur head necrosis, which is prepared from the following Chinese-medicinal materials according to a certain proportion: 18 to 22g of eagle wood, 18 to 22g of rehmannia root, 18 to 22g of corydalis tuber, 18 to 22g of cinnabar, 28 to 32g of kudzuvine root, 28 to 32g of myrrh, 18 to 22g of draconis resin, 48 to 52g of crab, 18 to 22g of edible tulip, 18 to 22g of alkanna tinctoria, 18 to 22g of safflower, 18 to 22g of ructus viticis, 18 to 22g of leech.

Description

A kind of medicine for external use for the treatment of femur head necrosis
The present invention relates to a kind of medicine for external use for the treatment of osteonecrosis of femoral head, belong to the Chinese medicine formulation art.
Hip joint is one of human body six big joints, is that human repeating motion is maximum, and the maximum joint of femoral head carrying in case necrose, will become a great problem in the medical domain, be called " new cancer ".General traditional medical science viewpoint thinks that bone necrosis, particularly femur head necrosis can not repair, and is irreversible.Therefore replace artificial joint, substitute the main treatment means that has just become this disease with prosthese.Artificial femoral head replacement's infectious-related complication is difficult to overcome, and occur to infect, loosening, joint stiffness, pain etc., can cause patient's lifelong disability.Research to the femur head necrosis paathogenic factor, be commonly considered as the necrosis that blood supply disorder causes in the femoral head, under this theoretical direction, treatment means is a purpose to improve the blood supply environment, has occurred Therapeutic Method such as vascular transplant, muscle flap vessel pedicle transplantation, bone lobe dislocation art, fetus cartilage dislocation art, interventional therapy in succession.Tcm therapy is based on blood circulation promoting and blood stasis dispelling, bone and muscle strengthening, nourishing the liver and kidney, and external treatment adopts the plaster external application.Above-mentioned therapy is to reparation, the treatment of necrotic femoral head, and the throughput fractional analysis does not still have final conclusion at aspects such as pathology, histologys.
Rationale is breakthrough to be discovered, the femur head necrosis paathogenic factor is not ischemic femoral head and blood supply disorder, but ultrastructure changes in the femoral head, internal stress of bone changes, the piezoelectric property of bone and electrokinetic property disorder, the electrical environment disequilibrium produces potential difference.This electrical environment destroys reason medicine source property, mechanicalness and chemical reason.Therapeutic Method then to improve the bio electricity environment, restores balance it.According to this theory, the inventor invents and has developed Huang Shi therapeutic apparatus for femoral head necrosis (China Patent No. CN92111451.6), is applied to the patient and has obtained excellent curative, and in order to improve curative effect, the inventor has developed the serial Chinese medicine that cooperates this instrument to use.
The object of the invention then provides the medicine for external use that a kind of Huang Shi of cooperation femoral head therapeutic instrument uses.
Medicine of the present invention is that the Chinese medicine with following proportioning (weight ratio) is the medicine for external use that raw material is made:
Lignum Aquilariae Resinatum 18-22g Radix Rehmanniae 18-22g Rhizoma Corydalis 18-22g
Cinnabaris 18-22g Radix Puerariae 28-32g Myrrha 28-32g
Sanguis Draxonis 18-22g Eriocheir sinensis 48-52g Pseudobulbus cremastrae seu pleiones 18-22g
Radix Arnebiae (Radix Lithospermi) 18-22g Flos Carthami 18-22g Fructus Viticis 18-22g
Hirudo 18-22g
The preparation method of medicine for external use of the present invention is with the oven dry of above-mentioned raw materials medicine, is ground into smalls, packing, every bag 10g.
Medicine of the present invention and Huang Shi therapeutic apparatus for femoral head necrosis are used.During use with medicine of the present invention with gingerade furnishing pasty state, spread on the acupuncture point (occupy Liao, Xuanzhong, in all) with gauze effective components of Chinese medicinal imported in the femoral head, a twice-daily, each was a course of treatment in one time three months sooner or later.
Medicine of the present invention can be repaired the femoral head articular surface, improves the joint space, recovers hip joint function, can be used for treating femur head necrosis, hip joint hyperplasia, and arthralgia is stiff.
Medicine of the present invention in use uses through clinical 1027 examples, and 1782 hip joint treatments are analyzed, and total effective rate reaches 97.2%, and cure rate reaches 54.2%.Wherein:
1, improve hip joint function, take care of oneself, the hip joint activity is normal substantially, outer bend, interior receipts, bend hip, after stretch and reach positive physiological function scope person 842 examples, account for sum 41.5%
2, collapse of the femoral head, acetabular bone are destroyed, the joint stiffness patient removes sequestrum by treatment, the area of new bone structure occurs, and joint space improver 212 examples account for sum 11.9%.
3, pain relief, normal, the femoral head carrying improvement of terms of walking can be adhered to worker's 362 examples, accounts for sum 19.8%.
4, femur head necrosis is the sclerosis ischemic necrosis, the loose type patient of femoral head hypertrophy dwindles by the treatment femoral head, and improve the joint space, area of new bone girder person 126 examples occur, accounts for sum 7.3%.
5, femur head necrosis is molten bone destruction, a head distortion subluxation or a complete dislocation occur, also receives and resets through treating remaining femoral head, and sequestrum is removed, and newborn carrying bone trabecula improves the carrying environment, can the person's of taking care of oneself 137 examples, account for 7.9%.
6, femur head necrosis has been replaced artificial joint, pain and is liied in bed unbearably and can not walk, and through the treatment pain relief, can hold and turn walker 18 examples, accounts for sum 1.05%.
7, femur head necrosis underwent operative treatment, joint capsule destroyed hip joint structure biomechanics occurs and change, and nonresponder's 49 examples account for sum 2.8%.
Embodiment:
Composition of raw materials is as follows
Lignum Aquilariae Resinatum 20g Radix Rehmanniae 20g Rhizoma Corydalis 20g Cinnabaris 20g Radix Puerariae 30g
Myrrha 20g Sanguis Draxonis 20g Eriocheir sinensis 50g Pseudobulbus cremastrae seu pleiones 20g Radix Arnebiae (Radix Lithospermi) 20g
Flos Carthami 20g Fructus Viticis 20g Hirudo (processing) 20g
With above-mentioned medical material oven dry, be ground into fine flour, packing, every bag 10g.

Claims (2)

1, a kind of medicine for the treatment of femur head necrosis is characterized in that it is the topical agent made from following proportion raw material:
Lignum Aquilariae Resinatum 18-22g Radix Rehmanniae 18-22g Rhizoma Corydalis 18-22g
Cinnabaris 18-22g Radix Puerariae 28-32g Myrrha 28-32g
Sanguis Draxonis 18-22g Eriocheir sinensis 48-52g Pseudobulbus cremastrae seu pleiones 18-22g
Radix Arnebiae (Radix Lithospermi) 18-22g Flos Carthami 18-22g Fructus Viticis 18-22g
Hirudo 18-22g
2,, it is characterized in that it is the topical agent made from following proportion raw material according to the medicine of claim 1:
Lignum Aquilariae Resinatum 20g Radix Rehmanniae 20g Rhizoma Corydalis 20g Cinnabaris 20g Radix Puerariae 30g
Myrrha 20g Sanguis Draxonis 20g Eriocheir sinensis 50g Pseudobulbus cremastrae seu pleiones 20g Radix Arnebiae (Radix Lithospermi) 20g
Flos Carthami 20g Fructus Viticis 20g Hirudo (processing) 20g
CN94114838A 1994-08-13 1994-08-13 Drug for exterior use for treating necrosis of femoral head Expired - Fee Related CN1043307C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN94114838A CN1043307C (en) 1994-08-13 1994-08-13 Drug for exterior use for treating necrosis of femoral head

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN94114838A CN1043307C (en) 1994-08-13 1994-08-13 Drug for exterior use for treating necrosis of femoral head

Publications (2)

Publication Number Publication Date
CN1121817A CN1121817A (en) 1996-05-08
CN1043307C true CN1043307C (en) 1999-05-12

Family

ID=5037212

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94114838A Expired - Fee Related CN1043307C (en) 1994-08-13 1994-08-13 Drug for exterior use for treating necrosis of femoral head

Country Status (1)

Country Link
CN (1) CN1043307C (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1056994C (en) * 1997-10-06 2000-10-04 王令喜 External-use ointment for treating necrosis of head of femur
CN1076617C (en) * 1999-06-16 2001-12-26 王松彪 Medicine specially for treating caput femoris necrosis, and method for preparing same
CN1101219C (en) * 1999-12-09 2003-02-12 张印昌 Chinese-medicinal pills for treating ischemic necrosis of femur head

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1089164A (en) * 1993-10-30 1994-07-13 王占礼 The Chinese medicine preparation and the method for making thereof of treatment femoral head necrosis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1089164A (en) * 1993-10-30 1994-07-13 王占礼 The Chinese medicine preparation and the method for making thereof of treatment femoral head necrosis

Also Published As

Publication number Publication date
CN1121817A (en) 1996-05-08

Similar Documents

Publication Publication Date Title
CN1389252A (en) Composite medicine for treating femoral head necrosis
CN1895332A (en) Oral and externally-applied Chinese medicinal preparation for treating osteoproliferation and its production
CN105982976A (en) Osteal penetrant for treating osteoarticular diseases and preparation method thereof
CN1189201C (en) Externally applied Chinese medicine for treating osteoarthropathy and its prepn process
CN1043307C (en) Drug for exterior use for treating necrosis of femoral head
CN1054520C (en) Drug for exterior use for treating necrosis of femoral head
CN1049133C (en) Oral medicine for treating necrosis of femoral head
CN1043308C (en) Drug for exterior use for treating necrosis of femoral head
CN1284580C (en) Bone Activating stasis transforming capsule
CN110840861B (en) Cervical vertebra plaster for clearing and activating channels and collaterals, and preparation method and application thereof
CN1324650A (en) Effective medicine for treating cervical vertebra disease as one kind of intractable disease
CN109432309B (en) Traditional Chinese medicine composition, external medicinal liquor, and preparation method and application thereof
CN1063650C (en) Chinese medicinal pill for curing rheumatism and rheumatoid disease and its preparation method
CN1443550A (en) Chinese medicine for curing necrosis of femoral head
CN1076614C (en) Exterior-applied powder medicine for treating lumbar intervertebral disk protrusion and preparing process
CN111407815A (en) Ointment for treating lumbar intervertebral disc and osteodynia and preparation method thereof
CN108888736B (en) External-use bone reunion medicine and preparation method thereof
CN1250245C (en) Capsule for treating osteonecrosis and bone fracture
CN1636578A (en) Chinese kmedicine bolus for treating femoral head necrosis and its prepn process
CN108815415B (en) Externally-applied medicine for treating rheumatic ostealgia and preparation method thereof
CN101181570B (en) Externally used detumescence pain-relieving medical ointment for curing orthopaedics illness
CN1050289C (en) Quick-acting antirheumatic
CN1258533A (en) Rheumatism-treating medical liquor
CN1294953C (en) External Chinese materia medica preparation for treating leucoderma
CN1058867C (en) Drug composite for curing bone tuberculosis in fumigation

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee